← FDA Drug Approvals (Drugs@FDA)
LAMOTRIGINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: YILING · Approved 2021-12-08
Drug application
- FDA Application #
ANDA213949- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LAMOTRIGINE
- Generic name
- LAMOTRIGINE EXTENDED-RELEASE
- Active ingredients
- LAMOTRIGINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- YILING
- Manufacturer
- Yiling Pharmaceutical, Inc.
- First approval
- 2021-12-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown